Berapakah harga AIkido Pharma Inc. (AIKI)

Harga AIkido Pharma Inc. (AIKI) adalah $3.56

Apakah topi pasaran AIkido Pharma Inc. (AIKI)

Cap pasaran AIkido Pharma Inc. (AIKI) adalah $18.70M

Keuntungan AIkido Pharma Inc. (AIKI)

AIkido Pharma Inc., established in 1967 and headquartered in New York, New York, is a biotechnology company primarily engaged in pioneering small-molecule anti-cancer treatments. The firm, which operated as Spherix Incorporated until its rebranding in March 2021, possesses a robust therapeutic pipeline addressing various malignancies, including prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. Key drug candidates in its development portfolio include DHA-dFdC, targeting pancreatic cancer, and KPC34, a small molecule designed for the treatment of both AML and acute lymphoblastic leukemia. Furthermore, AIkido Pharma Inc. is advancing an antiviral platform engineered to hinder the proliferation of numerous viruses, such as the influenza virus, Ebolavirus, Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. The company holds strategic license agreements with several academic and research institutions, including the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences.

Tahun	Pendapatan	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Pendapatan

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	Pendapatan	Perbezaan Pendapatan	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	$5.27B	-	US
Argenx SE ARGX.US	$1.95B	-	NL
CSL Limited CSL.AX	$1.61B	-	AU
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR

Syarikat

Pendapatan

Perbezaan Pendapatan

Negara